Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1

IF 4.3 3区材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC

ACS Applied Electronic Materials Pub Date : 2024-04-04 DOI:10.1080/13880209.2024.2331060

Jiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, Weiqing Chen

引用次数: 0

Abstract

Cholangiocarcinoma with highly heterogeneous, aggressive, and multidrug resistance has a poor prognosis. Although babaodan (BBD) combined with cisplatin improved non-small cell lung cancer efficacy...

查看原文本刊更多论文

巴巴丹通过抑制 YAP1 克服胆管癌的顺铂耐药性

胆管癌具有高度异质性、侵袭性和多药耐药性，预后较差。虽然巴巴丹（BBD）与顺铂联用可改善非小细胞肺癌的疗效...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Electronic Materials Multiple-

CiteScore

7.20

自引率

4.30%

发文量

567